Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast
Malignant phyllodes tumor is a rare breast malignancy with sarcomatous overgrowth and with limited effective treatment options for recurrent and metastatic cases. Recent clinical trials indicated a potential for anti-angiogenic, anti-EGFR and immunotherapeutic approaches for patients with sarcomas,...
Main Authors: | Gatalica, Zoran, Vranic, Semir, Ghazalpour, Anatole, Xiu, Joanne, Ocal, Idris Tolgay, McGill, John, Bender, Ryan P., Discianno, Erin, Schlum, Aaron, Sanati, Souzan, Palazzo, Juan, Reddy, Sandeep, Pockaj, Barbara |
---|---|
Format: | Online |
Language: | English |
Published: |
Impact Journals LLC
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811491/ |
Similar Items
-
High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine
by: Gatalica, Zoran, et al.
Published: (2016) -
Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas
by: Smaglo, Brandon G., et al.
Published: (2015) -
PD-L1 Status in Refractory Lymphomas
by: Vranic, Semir, et al.
Published: (2016) -
Comprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: Analysis of 1806 cases
by: Gatalica, Zoran, et al.
Published: (2014) -
Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1
by: Gatalica, Zoran, et al.
Published: (2015)